Primary |
Product Used For Unknown Indication |
27.7% |
Urinary Tract Infection |
20.3% |
Drug Use For Unknown Indication |
12.5% |
Infection |
6.8% |
Pneumonia |
3.2% |
Diverticulitis |
2.8% |
Cystitis |
2.6% |
Lower Respiratory Tract Infection |
2.6% |
Prostatitis |
2.6% |
Unevaluable Event |
2.5% |
Sinusitis |
2.3% |
Bronchitis |
2.0% |
Prophylaxis |
2.0% |
Hypertension |
1.8% |
Cellulitis |
1.7% |
Pain |
1.6% |
Pseudomonas Infection |
1.4% |
Sepsis |
1.2% |
Pyrexia |
1.2% |
Kidney Infection |
1.1% |
|
Tendonitis |
13.5% |
Vomiting |
9.8% |
Tendon Rupture |
9.7% |
Tendon Pain |
7.1% |
Renal Failure Acute |
5.6% |
Rash |
5.6% |
Pain In Extremity |
4.9% |
Urticaria |
4.3% |
Rhabdomyolysis |
4.2% |
Tremor |
3.7% |
Tendon Disorder |
3.6% |
Weight Decreased |
3.5% |
Paraesthesia |
3.5% |
Toxic Epidermal Necrolysis |
3.4% |
Drug Interaction |
3.3% |
Tinnitus |
3.1% |
Urinary Tract Infection |
3.0% |
Pyrexia |
2.8% |
Mania |
2.7% |
Treatment Failure |
2.7% |
|
Secondary |
Product Used For Unknown Indication |
35.3% |
Drug Use For Unknown Indication |
12.7% |
Urinary Tract Infection |
7.8% |
Hypertension |
5.8% |
Pneumonia |
5.6% |
Infection |
4.1% |
Prophylaxis |
3.2% |
Drug Abuse |
3.0% |
Hiv Infection |
2.7% |
Pyrexia |
2.3% |
Bronchitis |
2.2% |
Bacteraemia |
2.1% |
Pain |
2.0% |
Sinusitis |
2.0% |
Pseudomonas Infection |
1.7% |
Staphylococcal Infection |
1.6% |
Diarrhoea |
1.5% |
Osteomyelitis |
1.5% |
Ill-defined Disorder |
1.4% |
Depression |
1.4% |
|
Vomiting |
14.5% |
Tendon Rupture |
10.7% |
Tendonitis |
8.1% |
Toxic Epidermal Necrolysis |
7.6% |
Renal Failure Acute |
7.2% |
Drug Hypersensitivity |
6.8% |
Urinary Tract Infection |
5.3% |
Rotator Cuff Syndrome |
5.1% |
Stevens-johnson Syndrome |
4.2% |
Weight Decreased |
3.6% |
Toxic Skin Eruption |
3.3% |
Drug Ineffective |
2.9% |
Pyrexia |
2.8% |
Visual Acuity Reduced |
2.8% |
Renal Failure |
2.7% |
Rhabdomyolysis |
2.7% |
Drug Rash With Eosinophilia And Systemic Symptoms |
2.5% |
Loss Of Consciousness |
2.5% |
Pain In Extremity |
2.5% |
Tendon Disorder |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
31.7% |
Drug Use For Unknown Indication |
12.9% |
Prophylaxis |
8.9% |
Pain |
5.8% |
Crohn's Disease |
5.0% |
Hypertension |
4.5% |
Multiple Myeloma |
3.7% |
Nausea |
2.7% |
Infection |
2.5% |
Hiv Infection |
2.3% |
Depression |
2.3% |
Acute Myeloid Leukaemia |
2.3% |
Constipation |
2.2% |
Contraception |
2.0% |
Urinary Tract Infection |
2.0% |
Breast Cancer |
2.0% |
Infection Prophylaxis |
2.0% |
Anxiety |
1.8% |
Prophylaxis Of Nausea And Vomiting |
1.7% |
Pneumonia |
1.6% |
|
Vomiting |
11.9% |
Urinary Tract Infection |
8.2% |
Weight Decreased |
7.8% |
Sepsis |
6.4% |
Pyrexia |
6.2% |
Thrombocytopenia |
6.2% |
Pneumonia |
5.9% |
Pulmonary Embolism |
5.3% |
White Blood Cell Count Decreased |
5.3% |
Pain |
5.2% |
Renal Failure Acute |
4.4% |
Death |
3.7% |
Febrile Neutropenia |
3.3% |
Nausea |
3.3% |
Septic Shock |
3.3% |
Respiratory Failure |
3.1% |
Renal Failure |
2.9% |
Drug Ineffective |
2.6% |
Tachycardia |
2.5% |
Deep Vein Thrombosis |
2.5% |
|
Interacting |
Product Used For Unknown Indication |
27.6% |
Drug Use For Unknown Indication |
10.2% |
Mental Disorder |
8.2% |
Urinary Tract Infection |
7.0% |
Hypertension |
5.3% |
Leukocytosis |
5.1% |
Periorbital Cellulitis |
3.4% |
Atrial Fibrillation |
3.2% |
Pneumonia |
3.1% |
Infection |
2.9% |
Chronic Obstructive Pulmonary Disease |
2.7% |
Endocarditis Bacterial |
2.7% |
Pain |
2.7% |
Bladder Pain |
2.6% |
Lung Transplant |
2.6% |
Pyrexia |
2.6% |
Pulmonary Embolism |
2.4% |
Chest Pain |
2.0% |
Procedural Pain |
1.9% |
Convulsion |
1.7% |
|
Drug Interaction |
18.2% |
Renal Failure Acute |
10.7% |
Weight Decreased |
8.3% |
International Normalised Ratio Increased |
5.8% |
Myalgia |
5.8% |
Homicide |
5.0% |
Hypoglycaemia |
5.0% |
Petechiae |
5.0% |
Rhabdomyolysis |
5.0% |
Electrocardiogram Qt Prolonged |
4.1% |
Pyrexia |
4.1% |
Intraocular Pressure Increased |
3.3% |
Penis Disorder |
3.3% |
Tremor |
3.3% |
Bronchitis |
2.5% |
Miosis |
2.5% |
Respiratory Tract Infection Bacterial |
2.5% |
Torsade De Pointes |
2.5% |
Blood Pressure Decreased |
1.7% |
Clostridium Difficile Colitis |
1.7% |
|